Geography Atrophy(GA) Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis By DelveInsight

Posted on
by

Geography Atrophy(GA) Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis By DelveInsight

DelveInsight has launched a new report on Geography Atrophy(GA) Market Insights, Epidemiology and Market Forecast-2030

“DelveInsight’s “Geographic Atrophy (GA) – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Geographic Atrophy (GA) , historical and forecasted epidemiology as well as the Geographic Atrophy (GA) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan”

Geographic Atrophy (GA) is an advanced form of Age-related Macular Degradation (AMD), which is characterized by progressive loss of visual function and is irreversible. It results from loss of photoreceptors, retinal pigment epithelium (RPE), and underlying choriocapillaris. Outer retina is demarcated by atrophic lesions, degrade macula (visual activity), expand and further form a mass including fovea.
 
American Academy of Ophthalmology (AAO) defines GA as a chronic progressive degeneration of the macula, as part of late-stage age-related macular degeneration (AMD). Starting typically in the perifoveal region and expanding to involve the fovea with time; leading to central scotomas and permanent loss of visual acuity. Over 8 million people are affected worldwide with GA, approximately 20% of all individuals with AMD.
 
 
 
 
 
 
Geographic Atrophy (GA) Epidemiology  

The Geographic Atrophy (GA) epidemiology division provide insights about historical and current Geographic Atrophy (GA) patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken

 

Report Key Facts:- 

1. According to World Health Organization (WHO), Age-related macular degeneration (AMD) ranks third among the global causes of visual impairment with a blindness prevalence of 8.7%. It is the primary cause of visual deficiency in industrialized countries.

2. According to Brader H et al. it is an estimate that about 7 to 10 million Americans have early signs of age-related macular degeneration (AMD) and are at significant risk for developing geographic atrophy (GA) and over a fifteen year time period, the estimated incidence of progression from early AMD to GA is nearly 14%.

 
3.Citations and Abstracts from April 2004 Archives of Ophthalmology suggests that the overall prevalence of neovascular AMD and/or geographic atrophy in the US population 40 years and older is estimated to be 1.47% (95% confidence interval, 1.38%-1.55%), with 1.75 million citizens having AMD.
 
 
Report Key Benefits

1. Geography Atrophy(GA) market report covers a descriptive overview and comprehensive insight of the Geography Atrophy(GA) epidemiology Geography Atrophy(GA) market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2. Geography Atrophy(GA) market report provides insights on the current and emerging therapies. 

3. Geography Atrophy(GA) market report offers a global historical and forecasted market covering drug outreach in 7 MM.

4. Geography Atrophy(GA) market report provides an edge that will help in developing business strategies by understanding trends shaping and driving the Cold Agglutinin Disease market

 
 
“According to DelveInsight’s analysis, males and females are equally affected, in case of Geographic Atrophy”
 
 
Major Key companies working Geography Atrophy(GA) that are given below:- 
 
1.  Apellis Pharmaceutical Co.
2. Alkeus Pharmaceutical Co. 
 
Name of drugs covered are given below:- 
 
1. APL-2
2. ALK-001
 
 
 

1. Key Insights

2. Executive Summary of Geographic Atrophy (GA)

3. Competitive Intelligence Analysis for Geographic Atrophy (GA)

4. Geographic Atrophy (GA) : Market Overview at a Glance

5. Geographic Atrophy (GA) : Disease Background and Overview

6. Patient Journey

7. Geographic Atrophy (GA) Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Geographic Atrophy (GA) Treatment

11. Marketed Products

12. Emerging Therapies

13. Geographic Atrophy (GA) : Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Geographic Atrophy (GA)

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Why should you buy this Geography Atrophy(GA) market report?

 

  • The report will help in developing business strategies by understanding trends shaping and driving the Geographic Atrophy (GA) market
  • To understand the future market competition in the Geographic Atrophy (GA) market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Geographic Atrophy (GA) in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Geographic Atrophy (GA) market
  • To understand the future market competition in the Geographic Atrophy (GA) market

 

Related Reports:-

1. Geography Atrophy(GA) Epidemiology Forecast to 2030

2. Geography Atrophy(GA) Pipeline Insights 2020

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/